Prominent staining for phospho-MEK1/2 (pS217/221) was detected in cancer cells of most high-risk HNSCCs (11 out of 15 cases) but was only detected in four out of 15 cases for the low-risk HNSCCs at different subsites (Figure 6F). Here, MAP2K1 is linked to cancer.